Immediate Impact
12 standout
Citing Papers
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Anti-PEG antibodies: Current situation and countermeasures
2024 Standout
Works of Ariel Raskin being referenced
Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ariel Raskin | 65 | 62 | 29 | 65 | 7 | 137 | |
| Remco Schrijver | 77 | 122 | 37 | 85 | 10 | 221 | |
| J. H. Gillespie | 63 | 49 | 54 | 59 | 4 | 144 | |
| Ashleigh C. Donaldson | 22 | 46 | 27 | 97 | 10 | 164 | |
| Jenna Anderson | 76 | 44 | 7 | 57 | 9 | 154 | |
| S. Edwards | 69 | 115 | 8 | 84 | 6 | 208 | |
| C. A. Manthei | 44 | 87 | 18 | 32 | 6 | 149 | |
| Nejash Abdela | 47 | 22 | 12 | 63 | 10 | 139 | |
| M. Jeggo | 37 | 45 | 6 | 74 | 8 | 113 | |
| L.S.B. Mellau | 74 | 71 | 16 | 47 | 10 | 190 | |
| Berecha Bayissa | 41 | 69 | 5 | 78 | 14 | 173 |
All Works
Login with ORCID to disown or claim papers
Loading papers...